Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT05080010
PHASE3
Adjuvant Chemotherapy for High-risk Postenucleation Retinoblastoma
Sponsor: Sun Yat-sen University
View on ClinicalTrials.gov
Summary
The purpose of this study is to determine the effect of 3 cycles of chemotherapy(CEV) in the treatment of Stage I enucleated retinoblastoma.
Official title: Three Cycles of Adjuvant Chemotherapy for the Patients With High-risk Retinoblastoma After Enucleation: Prospective Study
Key Details
Gender
All
Age Range
Any - Any
Study Type
INTERVENTIONAL
Enrollment
500
Start Date
2020-11-01
Completion Date
2030-12-31
Last Updated
2021-10-15
Healthy Volunteers
No
Conditions
Interventions
DRUG
3 cycles chemotherapy
Chemotherapy:vincristine,1.5mg/m2;carboplatin,560mg/ m2;etoposide,150 mg/ m2.monthly for the first three months.
Locations (1)
Zhongshan Ophthalmic Center, Sun Yat-sen University
Guangzhou, Guangdong, China